Maria-Luiza Saraiva-Pereira

14PUBLICATIONS
34CO-AUTHORS
Medical infection agents (incl. prions)Speech pathologyCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)Genome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 01, 2024
The parkin V380L variant is a genetic modifier of Machado-Joseph disease with impact on mitophagy.

Jonasz J Weber, Leah Czisch, Priscila Pereira Sena

|Jul 07, 2021
Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Gabriela Bolzan, Vanessa Bielefeldt Leotti, Camila Maria de Oliveira

|Mar 12, 2020
Free carnitine and branched chain amino acids are not good biomarkers in Huntington's disease.

Raphael Machado Castilhos, Marina Coutinho Augustin, José Augusto Dos Santos

|Oct 07, 2019
Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Rafaella Mergener, Gabriel Vasata Furtado, Eduardo Preusser de Mattos

|Jul 02, 2019
Minimal prevalence of Huntington's disease in the South of Brazil and instability of the expanded CAG tract during intergenerational transmissions.

Raphael Machado de Castilhos, José Augusto Dos Santos, Marina Coutinho Augustin

|Jun 13, 2019
State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change.

Gabriel Vasata Furtado, Camila Maria de Oliveira, Gabriela Bolzan

Pageof 3